Breaking News

Integrity Bio Announces Newly Validated Biotech Manufacturing Line

Plant expansion doubles fill/finish capacity.

By: Contract Pharma

Contract Pharma Staff

Integrity Bio has announced the validation of its second fill/finish manufacturing line. This plant expansion more than doubles the company’s manufacturing capacity to meet growing demand in the field.   Founded in 2003, Integrity Bio has established itself as a provider of Formulation Development, GMP Fill Finish Services, and Innovative Drug Delivery technologies to support biotechnology and pharmaceutical companies large and small who strive to save or improve the quality of human life throug...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters